UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 13 | Issue 3 | March 2026

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 12 Issue 1
January-2025
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2501424


Registration ID:
554081

Page Number

e187-e203

Share This Article


Jetir RMS

Title

DEVELOPMENT, VALIDATION AND STABILITY INDICATING STUDIES OF A NOVEL ROBUST ANALYTICAL METHOD FOR ANTI-NEOPLASTIC AGENT ESTIMATION USING LIQUID CHROMATOGRAPHY

Abstract

For the detection of enasidenib, an innovative reversed phase high performance liquid chromatography approach that is simple, fast, accurate, and selective was created and verified. The Symmetry ODS C18 (4.6 x 150 mm, 5 µm) column was used to make the separation. At a wavelength of 272 nm, the mobile phase utilized included ethanol: water adjusted with an orthophosphoric acid solution in a 50:50% v/v ratio in isocratic mode. For the determination of Enasidenib in bulk and its injected sample volume, the mobile-phase flow rate and the technique that was developed and validated were 1 ml/min and 10 μl, respectively. Enasidenib was shown to have a retention time of 2.8 ±0.2 minutes. Over a concentration range of 20 to 100µg/ml of Enasidenib, a solid linear interaction (r=0.999) was found. Enasidenib's limit of quantification (LOQ) and limit of detection (LOD) were determined to be 6.35 µg/ml and 2.6 µg/ml, respectively. The degree of recovery was found to be between 98 and 102%. The precision study's relative standard deviation was less than 2%. Enasidenib in bulk and marketed pharmaceutical dosage forms may be estimated using the devised approach since it is quick, easy, exact, specific, and accurate. The drug product was subjected to hydrolysis (acid and base hydrolysis), H2O2, thermal degradation, and light degradation during force degradation. Within the specified conditions, the percentage of deterioration for both Enasidenib was determined to be between 10 and 20%. The suggested techniques, which may be applied to the simultaneous estimate of Enasidenib in tablet dose form, were simple, precise, and cost-effective.

Key Words

Enasidenib, RP-HPLC, stability indicating study and ICH Q2 (R1) Guidelines.

Cite This Article

"DEVELOPMENT, VALIDATION AND STABILITY INDICATING STUDIES OF A NOVEL ROBUST ANALYTICAL METHOD FOR ANTI-NEOPLASTIC AGENT ESTIMATION USING LIQUID CHROMATOGRAPHY", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.12, Issue 1, page no.e187-e203, January-2025, Available :http://www.jetir.org/papers/JETIR2501424.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"DEVELOPMENT, VALIDATION AND STABILITY INDICATING STUDIES OF A NOVEL ROBUST ANALYTICAL METHOD FOR ANTI-NEOPLASTIC AGENT ESTIMATION USING LIQUID CHROMATOGRAPHY", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.12, Issue 1, page no. ppe187-e203, January-2025, Available at : http://www.jetir.org/papers/JETIR2501424.pdf

Publication Details

Published Paper ID: JETIR2501424
Registration ID: 554081
Published In: Volume 12 | Issue 1 | Year January-2025
DOI (Digital Object Identifier): http://doi.one/10.1729/Journal.43193
Page No: e187-e203
Country: hyderabad, telangana, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000216

Print This Page

Current Call For Paper

Jetir RMS